Yu-Hsin Tseng

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

The Kaohsiung journal of medical sciences

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

Molecular genetics & genomic medicine

Yu-Hsin Tseng

Yu-Hsin Tseng (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yu-Hsin Tseng Dec 01 2015

Taiwan

PhD :: Department of Pediatrics

Education History

Yu-Hsin Tseng

Taiwan

PHD

Publications

Yi-Ching Liu, Yu-Hsin Tseng, Yu-Hsin Kuan, Lin-Yen Wang, Shang-En Huang, Siao-Ping Tsai, Jwu-Lai Yeh, Jong-Hau Hsu
Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells. The Kaohsiung journal of medical sciences 40 (6) (2024)
Yi-Ching Liu, Yu-Hsin Tseng, Yu-Hsin Kuan, Lin-Yen Wang, Shang-En Huang, Siao-Ping Tsai, Jwu-Lai Yeh, Jong-Hau Hsu
Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells. The Kaohsiung journal of medical sciences 40 (6) (2024)
Yi-Ching Liu, Yu-Hsin Tseng, Yu-Hsin Kuan, Lin-Yen Wang, Shang-En Huang, Siao-Ping Tsai, Jwu-Lai Yeh, Jong-Hau Hsu
Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells. The Kaohsiung journal of medical sciences (2024)
Yin-Hwa Shih, Cheng-Chia Yu, Kai-Chi Chang, Yu-Hsin Tseng, Po-Jung Li, Shih Min Hsia, Kuo-Chou Chiu, Tzong-Ming Shieh
Synergistic Effect of Combination of a Temoporfin-Based Photodynamic Therapy with Potassium Iodide or Antibacterial Agents on Oral Disease Pathogens In Vitro. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
I-Chen Chen, Yi-Ching Liu, Yen-Hsien Wu, Shih-Hsing Lo, Shu-Chi Wang, Chia-Yang Li, Zen-Kong Dai, Jong-Hau Hsu, Chung-Yu Yeh, Yu-Hsin Tseng
Proteasome Inhibitors Decrease the Viability of Pulmonary Arterial Smooth Muscle Cells by Restoring Mitofusin-2 Expression under Hypoxic Conditions. Biomedicines 10 (4) (2022)
I-Chen Chen, Yi-Ching Liu, Yen-Hsien Wu, Shih-Hsing Lo, Zen-Kong Dai, Jong-Hau Hsu, Yu-Hsin Tseng
Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis. Cells 11 (9) (2022)
Shuo-Yu Wang, Yin-Hwa Shih, Tzong-Ming Shieh, Yu-Hsin Tseng
Proteasome Inhibitors Interrupt the Activation of Non-Canonical NF-κB Signaling Pathway and Induce Cell Apoptosis in Cytarabine-Resistant HL60 Cells. International journal of molecular sciences 23 (1) (2021)
I-Chen Chen, Shu-Chi Wang, Yi-Ting Chen, Hsin-Han Tseng, Po-Len Liu, Tzu-Chieh Lin, Hsin-En Wu, Yuan-Ru Chen, Yu-Hsin Tseng, Jong-Hau Hsu, Zen-Kong Dai, Jau-Ling Suen, Chia-Yang Li
Corylin Ameliorates LPS-Induced Acute Lung Injury via Suppressing the MAPKs and IL-6/STAT3 Signaling Pathways. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Pei-Chin Lin, Shyh-Shin Chiou, Wan-Yi Hsu, Yu-Mei Liao, Shih-Pien Tsai, Hsiu-Lan Su, Ping-Tao Lu, Yu-Hsin Tseng
Plasma levels of IL-1β and IL-37 in patients with severe haemophilia. The Journal of international medical research 48 (7) (2021)
Tzu-Ying Lee, Yu-Hsin Tseng
The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence. Biomolecules 10 (8) (2020)
Pei-Chin Lin, Chao-Neng Cheng, Hsi-Yuan Huang, Yu-Hsin Tseng, Ya-Sian Chang, Chien-Yu Lin, Jan-Gowth Chang
Congenital dyserythropoiesis anemia type Ia with a novel CDAN1 mutation diagnosed by whole exome sequencing. Molecular genetics & genomic medicine 8 (5) (2020)
Yin-Hwa Shih, Tong-Hong Wang, Tzong-Ming Shieh, Yu-Hsin Tseng
Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy. International journal of molecular sciences 20 (12) (2019)

Yu-Hsin Tseng.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yu-Hsin Tseng